Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$209.01 - $232.56 $77,124 - $85,814
-369 Reduced 7.75%
4,393 $959,000
Q4 2023

Jan 11, 2024

BUY
$197.69 - $227.29 $14,629 - $16,819
74 Added 1.58%
4,762 $1.08 Million
Q3 2023

Oct 19, 2023

SELL
$201.05 - $221.7 $7,036 - $7,759
-35 Reduced 0.74%
4,688 $942,000
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $12,715 - $14,479
60 Added 1.29%
4,723 $1.14 Million
Q1 2023

Apr 24, 2023

BUY
$213.32 - $257.83 $13,652 - $16,501
64 Added 1.39%
4,663 $1.07 Million
Q4 2022

Feb 15, 2023

SELL
$203.72 - $248.97 $10,186 - $12,448
-50 Reduced 1.08%
4,599 $1.08 Million
Q3 2022

Oct 27, 2022

SELL
$204.81 - $262.19 $6,144 - $7,865
-30 Reduced 0.64%
4,649 $952,000
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $96,237 - $125,041
450 Added 10.64%
4,679 $1.1 Million
Q1 2022

May 04, 2022

BUY
$259.82 - $298.18 $2,858 - $3,279
11 Added 0.26%
4,229 $1.12 Million
Q4 2021

Feb 02, 2022

SELL
$271.6 - $314.21 $115,430 - $133,539
-425 Reduced 9.15%
4,218 $1.33 Million
Q3 2021

Oct 27, 2021

BUY
$274.82 - $308.34 $33,253 - $37,309
121 Added 2.68%
4,643 $1.31 Million
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $134,750 - $148,804
-535 Reduced 10.58%
4,522 $1.25 Million
Q4 2020

Mar 10, 2021

SELL
$186.91 - $214.42 $93,455 - $107,210
-500 Reduced 9.0%
5,057 $1.03 Million
Q3 2020

Mar 10, 2021

SELL
$167.03 - $201.3 $501 - $603
-3 Reduced 0.05%
5,557 $1.05 Million
Q4 2019

Mar 10, 2021

BUY
$163.48 - $173.61 $908,948 - $965,271
5,560 New
5,560 $941,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Investment Advisory Services Inc Portfolio

Follow Investment Advisory Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Advisory Services Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investment Advisory Services Inc with notifications on news.